Apply for a Statement of Licensing Status.
The Statement of Licensing Status (SLS) attests a specified therapeutic product has been registered for use in Singapore. It is usually intended to facilitate the screening and preparation of product information by importing agents when considering bids made in response to an international tender.
The SLS provides details pertaining to the therapeutic product such as:
The SLS will be issued in the format as recommended by the World Health Organization.
You will need the following supporting documents to complete your application:
Refer to therapeutic product fees and turnaround time for more information.
Submit your application through PRISM. Ensure you have the following before you access the e-service:
If you encounter technical issues, e-mail the HSA helpdesk or call 6776 0168 (from 7.00 am to midnight daily).
Regulatory overview
Register your product
Apply for post-approval variation
Reclassify your product
Dealer's licensing and certification
Retain, cancel or transfer product registration
Risk management plan requirements
Report adverse events
Report or recall defective products
Retail pharmacy licensing
Clinical trials
Product consultation
Advertisements and promotions
CPP and SLS
International collaboration
Medicines quality and compliance monitoring
Listing of approvals and post-registration actions
Guidance documents
Fees and turnaround time
PRISM (Therapeutic products)
Infosearch